A Retrospective Study on Inotuzumab Ozogamicin in Infants and Young Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

被引：2
|
作者：
Brivio, Erica [1 ,2 ]
Hoogendijk, Raoull [1 ]
Chantrain, Christophe [3 ]
Rialland, Fanny [4 ]
Contet, Audrey [5 ]
Elitzur, Sarah [6 ]
Dalla-Pozza, Luciano [7 ]
Kallay, Krisztian [8 ]
Li, Chi Kong [9 ]
Kato, Motohiro [10 ]
Markova, Inna V. [11 ]
Schmiegelow, Kjeld [12 ]
Bodmer, Nicole [13 ]
Pieters, Rob [1 ]
Zwaan, Christian Michel [1 ,2 ]
机构：
[1] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[2] Erasmus MC, Dept Pediat Oncol Hematol, Sophia Childrens Hosp, Rotterdam, Netherlands
[3] CHC Liege, Clin Esperance, Div Pediat Hematol Oncol, Montegnee, Belgium
[4] CHU Nantes, Nantes, France
[5] CHRU Nancy, Childrens Hosp, Dept Hematol & Oncol, Vandoeuvre Les Nancy, France
[6] Schneider Childrens Med Ctr Israel, Pediat Hematol Oncol, Petah Tiqwa, Israel
[7] Childrens Hosp Westmead, Canc Ctr Children, Westmead, NSW, Australia
[8] Cent Hosp Southern Pest, Pediat Hematol & Stem Cell Transplantat Dept, Natl Inst Hematol & Infect Dis, Budapest, Hungary
[9] Chinese Univ Hong Kong, Dept Paediat, Prince Wales Hosp, Hong Kong, Peoples R China
[10] Natl Ctr Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan
[11] First Pavlov State Med Univ St Petersburg, Raisa Gorbacheva Mem Sci Inst Children Oncol Hema, St Petersburg, Russia
[12] Rigshosp Univ Hosp, Dept Pediat & Adolescent Med, Copenhagen, Denmark
[13] Univ Childrens Hosp Zurich, Zurich, Switzerland
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-126472
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3890
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Inotuzumab ozogamicin in infants and young children with relapsed or refractory acute lymphoblastic leukaemia: a case series*
    Brivio, Erica
    Chantrain, Christophe F.
    Gruber, Tanja A.
    Thano, Adriana
    Rialland, Fanny
    Contet, Audrey
    Elitzur, Sarah
    Dalla-Pozza, Luciano
    Kallay, Krisztian Miklos
    Li, Chi-kong
    Kato, Motohiro
    Markova, Inna
    Schmiegelow, Kjeld
    Bodmer, Nicole
    Breese, Erin H.
    Hoogendijk, Raoull
    Pieters, Rob
    Zwaan, Christian Michel
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (06) : 1172 - 1177
  • [2] Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
    Bhojwani, Deepa
    Sposto, Richard
    Shah, Nirali N.
    Rodriguez, Vilmarie
    Yuan, Constance
    Stetler-Stevenson, Maryalice
    O'Brien, Maureen M.
    McNeer, Jennifer L.
    Quereshi, Amrana
    Cabannes, Aurelie
    Schlegel, Paul
    Rossig, Claudia
    Dalla-Pozza, Luciano
    August, Keith
    Alexander, Sarah
    Bourquin, Jean-Pierre
    Zwaan, Michel
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Rheingold, Susan R.
    LEUKEMIA, 2019, 33 (04) : 884 - 892
  • [3] Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemia
    George, Binsah
    Kantarjian, Hagop
    Jabbour, Elias
    Jain, Nitin
    IMMUNOTHERAPY, 2016, 8 (02) : 135 - 143
  • [4] Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
    Deepa Bhojwani
    Richard Sposto
    Nirali N. Shah
    Vilmarie Rodriguez
    Constance Yuan
    Maryalice Stetler-Stevenson
    Maureen M. O’Brien
    Jennifer L. McNeer
    Amrana Quereshi
    Aurelie Cabannes
    Paul Schlegel
    Claudia Rossig
    Luciano Dalla-Pozza
    Keith August
    Sarah Alexander
    Jean-Pierre Bourquin
    Michel Zwaan
    Elizabeth A. Raetz
    Mignon L. Loh
    Susan R. Rheingold
    Leukemia, 2019, 33 : 884 - 892
  • [5] Inotuzumab Ozogamicin (Besponsa®) for Patients with relapsed or refractory acute lymphoblastic Leukemia (r/r ALL)
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (1-2) : 66 - 66
  • [6] Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL).
    Bhojwani, Deepa
    Sposto, Richard
    Shah, Nirali
    Rodriguez, Vilmarie
    O'Brien, Maureen Megan
    McNeer, Jennifer Lynn
    Loh, Mignon L.
    Rheingold, Susan R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
    Deepa Bhojwani
    Richard Sposto
    Nirali N. Shah
    Vilmarie Rodriguez
    Constance Yuan
    Maryalice Stetler-Stevenson
    Maureen M. O’Brien
    Jennifer L. McNeer
    Amrana Quereshi
    Aurelie Cabannes
    Paul Schlegel
    Claudia Rossig
    Luciano Dalla-Pozza
    Keith August
    Sarah Alexander
    Jean-Pierre Bourquin
    Michel Zwaan
    Elizabeth A. Raetz
    Mignon L. Loh
    Susan R. Rheingold
    Leukemia, 2019, 33 : 1061 - 1062
  • [8] Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden
    DeAngelo, Daniel J.
    Advani, Anjali S.
    Marks, David, I
    Stelljes, Matthias
    Liedtke, Michaela
    Stock, Wendy
    Goekbuget, Nicola
    Jabbour, Elias
    Merchant, Akil
    Wang, Tao
    Vandendries, Erik
    Neuhof, Alexander
    Kantarjian, Hagop
    O'Brien, Susan
    BLOOD CANCER JOURNAL, 2020, 10 (08)
  • [9] Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
    Luca Bertamini
    Jacopo Nanni
    Giovanni Marconi
    Mariachiara Abbenante
    Valentina Robustelli
    Francesco Bacci
    Antonella Matti
    Stefania Paolini
    Chiara Sartor
    Silvia Lo Monaco
    Maria Chiara Fontana
    Stefano De Polo
    Michele Cavo
    Antonio Curti
    Giovanni Martinelli
    Cristina Papayannidis
    BMC Cancer, 18
  • [10] Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden
    Daniel J. DeAngelo
    Anjali S. Advani
    David I. Marks
    Matthias Stelljes
    Michaela Liedtke
    Wendy Stock
    Nicola Gökbuget
    Elias Jabbour
    Akil Merchant
    Tao Wang
    Erik Vandendries
    Alexander Neuhof
    Hagop Kantarjian
    Susan O’Brien
    Blood Cancer Journal, 10
12345